Bellecapital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-24,237
| Closed | -$4.89M | – | 172 |
|
|
2023
Q1 | $4.89M | Buy |
24,237
+673
| +3% | +$136K | 1.22% | 26 |
|
|
2022
Q4 | $5.13M | Buy |
23,564
+666
| +3% | +$145K | 1.44% | 23 |
|
|
2022
Q3 | $4.51M | Buy |
22,898
+6,470
| +39% | +$1.27M | 1.38% | 22 |
|
|
2022
Q2 | $3.52M | Buy |
16,428
+15,035
| +1,079% | +$3.22M | 0.98% | 31 |
|
|
2022
Q1 | $396K | Sell |
1,393
-24
| -2% | -$6.82K | 0.13% | 131 |
|
|
2021
Q4 | $534K | Sell |
1,417
-42
| -3% | -$15.8K | 0.15% | 110 |
|
|
2021
Q3 | $602K | Buy |
1,459
+19
| +1% | +$7.84K | 0.18% | 98 |
|
|
2021
Q2 | $533K | Buy |
1,440
+39
| +3% | +$14.4K | 0.16% | 110 |
|
|
2021
Q1 | $406K | Buy |
+1,401
| New | +$406K | 0.13% | 129 |
|